Konk is more cost effective than the competition because it offers every element of care within one bundled financial package -- from diagnosis and physician review, to device fulfillment, and through the first 90 days of post-therapy patient support. Even if you have insurance, the competition is going to hit you with additional bills that you must pay out-of-pocket: copays for your multiple doctor visits; coinsurance for expensive diagnostic testing; high deductibles for your equipment, which you may not even be permitted to own. These surprise bills routinely exceed $2,000 per year. But Konk offers you price certainty: Initial diagnosis, device provision, and 90 days of therapy monitoring is locked in at $1199, and quarterly resupplies are only $199 and subject to your approval -- with no further bills to come. And Konk does not make you come back to the doctor every year, simply to receive a prescription for your resupplies: All Konk prescriptions have a lifetime horizon, and do not need to be re-written annually, and thus do not require a physician fee and inconvenient office visit -- so the savings accumulate for decades.

Yes, especially if your Konk visit was prompted by the notification of your smartwatch. The Konk diagnostic approach combines information technology with expert medical review. If you have reached out for medical care because you think you might have obstructive sleep apnea (OSA), there is an 80% chance you are correct. If that prompt came from a watch that is FDA-approved to detect OSA, there is a 98.5% chance that you are correct. By asking the proper screening questions and taking a relevant medical history, the Konk Digital Clinical Interview can achieve diagnostic accuracy comparable to a sleep laboratory. Keep in mind – single-night sleep studies can miss up to 25% of patients with OSA.

Konk has a practical philosophy: The best doctor is the one who is right in front of you. The best medicine is the one you’ll actually take. The best practice is the one that is always open and never has a wait.

Konk pledges to confirm all positive diagnoses within 3 business days of completing our assessment, compared to weeks or months with traditional methods. In general, the Konk medical doctors complete your clinical review by the next business day.

No special diagnostic equipment is required at any time – our physicians pay close attention to your interview responses and do not require further laboratory or overnight testing. In the famous words of Sir William Osler, the guiding force of modern medicine: “Listen to your patients – they’re telling you the diagnosis."

Yes, Konk accepts both HSA and FSA – and we encourage you to use it! If you have an HSA/FSA card, you use it exactly like a credit card at checkout – except you never get billed for anything, because you’ve already made the payment by funding your HSA/FSA account. And by using your HSA/FSA (which is funded with pre-tax income), you receive an effective discount on your Konk products equivalent to your tax bracket (e.g., an individual who pays 40% in annual taxes effectively receives a 40% discount on Konk).

Yes, Konk offers payment plans in which the monthly charge is about the cost of a gym membership -- and offers even greater fitness benefits.  In the form of your APAP device, you will receive life-saving therapy, a wearable sleep tracker that produces nightly metrics, and a medical monitoring system that alerts your sleep team to vital trends.  Whether paid for up front or with smaller installments, the premium value of the Konk bundle far exceeds the average monthly cost.

No, not at the present time. Though Konk understands that OAT is effective for some patients, positive airway pressure (PAP) therapy has been demonstrated to confer the greatest benefit to the greatest number of people. We have designed a system in which we can give you the most benefit in the shortest period of time. OAT requires fitting and customized manufacturing, which takes weeks to process, and has a lower efficacy rate than PAP – but Konk is constantly evaluating our customers’ options.